▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Fortune Brands Home & Security Q1 22 Earnings Conference Call At 4:30 PM ET

By RTTNews Staff Writer ✉ | Published: 4/28/2022 2:00 PM ET

Fortune Brands Home & Security, Inc. (FBHS) will host a conference call at 4:30 PM ET on April 28, 2022, to discuss Q1 22 earnings results.

To access the live webcast, log on to https://ir.fbhs.com/events/event-details/q1-2022-earnings-conference-call

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In November 2022

Biotech Stocks Facing FDA Decision In November 2022

Biotech Stocks Facing FDA Decision In October 2022

Biotech Stocks Facing FDA Decision In October 2022

Latest Updates on COVID-19

U.S. Covid Test Positivity Jumps To 12%

U.S. Covid Test Positivity Hits 10%

Walgreens Teams With DoorDash, Uber To Offer Free Paxlovid Delivery

Pfizer Seeks FDA Approval For Bivalent COVID-19 Vaccine In Kids Under 5

U.S. Covid Test Positivity Rises Above 9%

Read More

COVID-19: Drugs in Development

RELATED NEWS

Fortune Brands Home & Security, Inc. Q3 Profit Increases, beats estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Japanese Billionaire Picks Crew Including Artists For SpaceX's Flight To The Moon

SpaceX Launches 40 OneWeb Satellites

Google To Combine Maps And Waze Teams

Google, Microsoft, Oracle, Amazon Awarded $9 Bln Worth Pentagon Cloud Deal

Juul Settles More Than 5,000 Lawsuits In US

Apple To Use US-made Microchips From TSMC's New Arizona Factory

Favorina Branded Advent Calendar Premium Chocolate Recalled

Pfizer Seeks FDA Approval For Bivalent COVID-19 Vaccine In Kids Under 5

Kraft Heinz Recalls RTE Ham And Cheese Loaf Products

Foxconn's IPhone Plant In China May Resume Full Production In Late Dec- Early Jan.

Nestle Purina Recalls Certain Pro Plan Dog Food

James Farms Frozen Raspberries Recalled

Nkarta - Engineering Allogeneic Natural Killer Cells To Beat Cancer

Novartis: Phase III PSMAfore Study With Pluvicto Meets Primary Endpoint

FOX's Special Committee Issues Update On Review Of Potential Transaction

Apple To Use US-made Microchips From TSMC's New Arizona Factory

AstraZeneca Reports Positive Survival In Phase 3 Trial Of ENHERTU In HER2 Metastatic Breast Cancer

Nestle Purina Recalls Certain Pro Plan Dog Food

Eli Lilly: Jardiance Improves Overall Blood Sugar Control In Children With Type 2 Diabetes

Pfizer Seeks FDA Approval For Bivalent COVID-19 Vaccine In Kids Under 5

Gossamer Bio: Seralutinib Meets Primary Endpoint In Phase 2 Study In Pulmonary Arterial Hypertension

IP Group: Portfolio Company Istesso's MBS2320 Gets FDA Fast Track And Orphan Drug Designation

Cheniere Announces Cash Tender Offer - Quick Facts

Kraft Heinz Recalls RTE Ham And Cheese Loaf Products

EU Court Of Justice Orders Google To Remove Manifestly Inaccurate Data

FALK Group To Acquire Salzgitter Bauelemente

AstroNova Q3 Adj. Profit Rises; Revenue Up 36.6%

Hargreaves Lansdown Names Dan Olley CEO

Walgreens Boots Alliance Sells AmerisourceBergen Shares For About $1.0 Bln

Google To Combine Maps And Waze Teams

TFF Pharma CEO Glenn Mattes To Resign; Harlan Weisman Appointed As Interim CEO

Eli Lilly: Jardiance Improves Overall Blood Sugar Control In Children With Type 2 Diabetes

Entain Plc Announces Refinancing Of EUR 1,125 Mln Term Loan B Due March 2024

Associated British Foods Backs Annual Outlook

Keurig Dr Pepper Reveals 30% Ownership In Nutrabolt

Lululemon Drops 11% Following Q4, Annual Outlook